The U.S. Food and Drug Administration has put Novavax's trial of an experimental COVID-flu vaccine combination on hold after ...

The US Food and Drug Administration (FDA) has updated the US label for French pharma major Sanofi’s Flublok (Influenza ...

Sanofi (SNYNF, SNY) said that the U.S. Food and Drug Administration has updated the label for FLUBLOK (Influenza Vaccine) to include ...

Novavax said a participant enrolled in a mid stage study of the combination vaccine last month reported symptoms of motor ...

Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put the biooharma's flu ...

The hold, which was made in response to a serious adverse event report, could impact the company’s plans to start a Phase 3 ...

"Today, we're proud to announce an important update to our label for FLUBLOK, from one of Sanofi's largest flu vaccine safety studies ever done in pregnant individuals, an important at-risk ...

Sanofi launches high-dose egg-based quadrivalent influenza vaccine (QIV-HD) in the UK ·       Developed with a higher antigen content to increase protection in older adults, a population at greater ...

NVAX's COVID-19-flu combination and stand-alone flu vaccines have been placed on hold after a study participant who took the ...

This summary highlights global health-related news, including the WHO's approval of a vaccine for adolescents, France seeking ...

France considers blocking Sanofi's $16 billion consumer division sale to U.S. firm CD&R, citing concerns over healthcare ...